Literature DB >> 15661650

Macho-1 functions as transcriptional activator for muscle formation in embryos of the ascidian Halocynthia roretzi.

Kaichiro Sawada1, Yusuke Fukushima, Hiroki Nishida.   

Abstract

Various kinds of maternal factor that play crucial roles in embryogenesis are present and localized in the ascidian egg cytoplasm. Localized maternal mRNA of the macho-1 gene is a muscle determinant in the embryo of the ascidian Halocynthia roretzi. The macho-1 protein has a zinc-finger domain and accumulates in nuclei, being expected to function as a DNA-binding transcription factor. In the present study, we show that macho-1 is, indeed, a DNA-binding transcriptional activator, and directly or indirectly regulates the expression of six downstream genes. Macho-1 was required and sufficient for expression of the muscle actin, myosin, calcium transporter, myogenic factor, Tbx6, and snail genes, whose expression is initiated in muscle blastomeres at the cleavage stages in normal embryos. Furthermore, when macho-1 conjugated with a transcription-repression domain of Drosophila engrailed (En(R)) was expressed in embryos, it repressed expression of these downstream genes. In contrast, expression of macho-1 fused with a transcription-activation domain of VP16 caused ectopic expression of these muscle genes in non-muscle blastomeres. PCR-assisted binding-site selection and gel-retardation assay showed that macho-1 protein binds to the consensus target sequence (TGGGTGGTC) for GLI/Zic-family proteins, and that three guanine residues with underlines are crucial for the specificity. The 5' promoter region of the muscle actin gene supported expression of the reporter gene only in muscle cells at late stage. By contrast, when the target sequence was added to the promoter, it well reproduced early expression of muscle actin at the cleavage stage, indicating that macho-1 can recognize the target sequence in vivo. In conclusion, the maternal muscle determinant macho-1 functions as a transcription factor that positively regulates gene expression for muscle formation in ascidian embryos.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661650     DOI: 10.1016/j.modgep.2004.09.003

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  7 in total

1.  The functional analysis of Type I postplasmic/PEM mRNAs in embryos of the ascidian Halocynthia roretzi.

Authors:  Yoriko Nakamura; Kazuhiro W Makabe; Hiroki Nishida
Journal:  Dev Genes Evol       Date:  2005-12-21       Impact factor: 0.900

2.  FGF signaling induces mesoderm in the hemichordate Saccoglossus kowalevskii.

Authors:  Stephen A Green; Rachael P Norris; Mark Terasaki; Christopher J Lowe
Journal:  Development       Date:  2013-01-23       Impact factor: 6.868

3.  Temporal regulation of the muscle gene cascade by Macho1 and Tbx6 transcription factors in Ciona intestinalis.

Authors:  Jamie E Kugler; Stefan Gazdoiu; Izumi Oda-Ishii; Yale J Passamaneck; Albert J Erives; Anna Di Gregorio
Journal:  J Cell Sci       Date:  2010-07-15       Impact factor: 5.285

4.  FGF9/16/20 and Wnt-5alpha signals are involved in specification of secondary muscle fate in embryos of the ascidian, Halocynthia roretzi.

Authors:  Miki Tokuoka; Gaku Kumano; Hiroki Nishida
Journal:  Dev Genes Evol       Date:  2007-05-30       Impact factor: 2.116

5.  Regulation of the number of cell division rounds by tissue-specific transcription factors and Cdk inhibitor during ascidian embryogenesis.

Authors:  Mami Kuwajima; Gaku Kumano; Hiroki Nishida
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  Modular co-option of cardiopharyngeal genes during non-embryonic myogenesis.

Authors:  Maria Mandela Prünster; Lorenzo Ricci; Federico D Brown; Stefano Tiozzo
Journal:  Evodevo       Date:  2019-03-05       Impact factor: 2.250

7.  Purification of mitochondrial proteins HSP60 and ATP synthase from ascidian eggs: implications for antibody specificity.

Authors:  Janet Chenevert; Gerard Pruliere; Hirokazu Ishii; Christian Sardet; Takahito Nishikata
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.